Endovastec's Share Price Soared 207% On The First Day Of Listing

On July 22, Endovastec was officially listed on the Shanghai Stock Exchange. After Endovastec's IPO, it's stock price increase by 207% on the first day of listing, the stock price is at 142 RMB per stock. As of the end of June 2019, Endovastec's total assets were 350 million RMB, and the net assets attributable to shareholders of the parent company was 279 million RMB. From January to June 2019, Endovastec's total revenue was 171 million RMB, and the net profit attributable to shareholders of the parent company was 85.01 million RMB.

Endovastec is a company that develops, manufactures and markets medical devices for aortic and peripheral vascular interventions. Its main products are aortic stent graft system, peripheral vascular stent system and peripheral vascular balloon dilatation catheter.